Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial-Reference-Cited by-同舟云学术

Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial

Published:2022-03 Issue:3 Volume:23 Page:e105-e115
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Zhu Xiaofei,Cao Yangsen,Liu Wenyu,Ju Xiaoping,Zhao Xianzhi,Jiang Lingong,Ye Yusheng,Jin Gang,Zhang Huojun

Publisher

Elsevier BV

Subject

Oncology

Reference33 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial;Oettle;JAMA,2013

3. Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma;Royal;J Immunother,2010

4. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N Engl J Med,2012

5. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody;Dewan;Clin Cancer Res,2009

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncoding Ribonucleic Acids (RNAs) May Improve Response to Immunotherapy in Pancreatic Cancer;ACS Pharmacology & Translational Science;2024-08-07

2. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma;World Journal of Clinical Oncology;2024-07-24

3. Escalated‐dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States;Cancer Medicine;2024-06

4. Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery;Journal of Clinical Medicine;2024-04-30

5. Treatment patterns and survival outcomes in patients with non-metastatic early-onset pancreatic cancer;World Journal of Gastroenterology;2024-03-28